Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Shares Outstanding (Diluted Average) (2024 - 2025)

Historic Shares Outstanding (Diluted Average) for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $51.4 million.

  • Kestra Medical Technologies' Shares Outstanding (Diluted Average) rose 15836.2% to $51.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $51.4 million, marking a year-over-year increase of 15836.2%. This contributed to the annual value of $24.6 million for FY2025, which is 2362.72% up from last year.
  • Per Kestra Medical Technologies' latest filing, its Shares Outstanding (Diluted Average) stood at $51.4 million for Q4 2025, which was up 15836.2% from $51.3 million recorded in Q3 2025.
  • Kestra Medical Technologies' Shares Outstanding (Diluted Average)'s 5-year high stood at $51.4 million during Q4 2025, with a 5-year trough of $19.9 million in Q1 2024.